Cargando…
Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669486/ https://www.ncbi.nlm.nih.gov/pubmed/33201344 http://dx.doi.org/10.1007/s00592-020-01630-5 |
| _version_ | 1783610581820899328 |
|---|---|
| author | Solerte, Sebastiano Bruno D’Addio, Francesca Fiorina, Paolo |
| author_facet | Solerte, Sebastiano Bruno D’Addio, Francesca Fiorina, Paolo |
| author_sort | Solerte, Sebastiano Bruno |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7669486 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Milan |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76694862020-11-18 Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” Solerte, Sebastiano Bruno D’Addio, Francesca Fiorina, Paolo Acta Diabetol Letter to the Editor Springer Milan 2020-11-17 2021 /pmc/articles/PMC7669486/ /pubmed/33201344 http://dx.doi.org/10.1007/s00592-020-01630-5 Text en © Springer-Verlag Italia S.r.l., part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Solerte, Sebastiano Bruno D’Addio, Francesca Fiorina, Paolo Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” |
| title | Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” |
| title_full | Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” |
| title_fullStr | Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” |
| title_full_unstemmed | Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” |
| title_short | Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19” |
| title_sort | reply to letter to the editor regarding “use of dpp-4 inhibitors in patients with covid-19” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669486/ https://www.ncbi.nlm.nih.gov/pubmed/33201344 http://dx.doi.org/10.1007/s00592-020-01630-5 |
| work_keys_str_mv | AT solertesebastianobruno replytolettertotheeditorregardinguseofdpp4inhibitorsinpatientswithcovid19 AT daddiofrancesca replytolettertotheeditorregardinguseofdpp4inhibitorsinpatientswithcovid19 AT fiorinapaolo replytolettertotheeditorregardinguseofdpp4inhibitorsinpatientswithcovid19 |